image
Exagen Inc. XGN
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 6.95
2.72 %
$ 124 M
Market Cap
-7.73
P/E
BALANCE SHEET
44.7 M ASSETS
-21.52%
Growth Rates
1Year -21.52%
3Years -28.73%
5Years -12.74%
7Years 11.86%
10Years 10.51%
35.1 M LIABILITIES
2.62%
Growth Rates
1Year 2.62%
3Years -3.00%
5Years 1.49%
7Years 4.97%
10Years 8.19%
9.54 M EQUITY
-57.96%
Growth Rates
1Year -57.96%
3Years -51.75%
5Years -29.72%
7Years 22.15%
10Years 35.69%
BALANCE SHEET DECOMPOSITION
Balance Sheet Exagen Inc.
image
Current Assets 36.5 M
Cash & Short-Term Investments 22 M
Receivables 7.84 M
Other Current Assets 6.58 M
Non-Current Assets 8.23 M
Long-Term Investments 0
PP&E 7.68 M
Other Non-Current Assets 550 K
49.31 %17.53 %14.73 %17.19 %Total Assets$44.7m
Current Liabilities 13.5 M
Accounts Payable 4.14 M
Short-Term Debt 423 K
Other Current Liabilities 8.95 M
Non-Current Liabilities 21.6 M
Long-Term Debt 19.8 M
Other Non-Current Liabilities 1.82 M
11.77 %25.45 %56.39 %5.18 %Total Liabilities$35.1m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 22.0 36.5 62.4 99.4 57.4 72.1 13.2 11.2 2.5 4.6 7.7 2.7
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 7.8 6.6 6.1 9.7 8.9 5.7 6.0 0.6 0 0 54 K 0
Inventory 0 2.9 1.8 1.1 1.2 1.4 1.0 0.5 0 0 0 0
Other Current Assets 0.9 1.9 2.3 2.5 4.2 3.5 2.2 1.4 1.4 0.5 0.2 0.8
Total Current Assets 36.5 47.8 72.6 112.7 70.5 81.2 21.3 13.3 3.9 5.1 8.0 3.6
PP&E 7.7 8.5 13.1 4.8 2.1 1.4 1.6 1.3 1.6 1.5 1.2 0.9
Intangible Assets 0 0 0 5.5 5.5 5.5 0 0.1 0.5 0.8 1.0 1.2
Goodwill 0 0 0 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5
Long Term Investments 0 0 0.2 100 K 100 K 100 K 100 K 100 K 0 0 0 0
Other Long Term Assets 0.6 0.6 0.5 (0.4) (0.5) 0.2 24 K (0.3) 3.1 2.5 0.7 63 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 44.7 56.9 86.2 123.4 78.4 88.3 28.9 20.4 14.6 17.1 16.5 11.3
LIABILITIES
Accounts Payable 4.1 3.1 3.0 2.5 3.0 1.5 1.3 1.8 2.2 1.8 0.4 0.3
Short Term Debt 0.4 1.7 1.9 0.6 0.3 0.2 81 K 27 K 25.9 18.5 8.9 1.2
Other Current Liabilities 8.9 7.0 4.6 6.2 5.4 4.2 7.6 3.2 6.8 4.0 1.2 0.8
Total Current Liabilities 13.5 11.9 9.6 9.3 8.8 5.9 9.0 5.0 34.9 26.3 10.6 2.4
Long Term Debt 19.8 22.0 33.3 27.5 26.7 25.9 24.9 18.9 0 1.7 0 1.4
Deferred Tax Income 0 0 1.4 0.3 0.2 0.3 0.2 0.2 0.4 0 0 0
Other Liabilities 1.8 0.4 0.9 1.4 0.9 0.6 (1.2) (0.6) 1.5 1.8 5.4 2.7
Total Liabilities 35.1 34.2 43.8 38.5 36.5 32.7 35.6 25.0 36.8 31.2 16.0 6.4
EQUITY
Common Stock 18 K 17 K 17 K 16 K 13 K 13 K 12 K 12 K 12 K 12 K 10 K 10 K
Retained Earnings (294.3) (279.2) (255.5) (208.1) (181.3) (164.6) (152.6) (147.6) (108.5) (89.3) (74.3) (60.8)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 (88.3) (1.8) (2.2) (2.2) (1.6) (1.3) (1.1)
Total Equity 9.5 22.7 42.5 84.9 41.8 55.7 (6.7) (4.6) (22.2) (14.1) 0.5 4.8
Total Liabilities and Equity 44.7 56.9 86.2 123.4 78.4 88.3 28.9 20.4 14.6 17.1 16.5 11.3
SHARES OUTSTANDING
Common Shares Outstanding 18.2 17.7 17.1 16.0 12.7 12.6 63 K 63 K 62.8 K 56.4 K 53.7 K 35.4 K